alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-D-GlcpNAc

Term ID

CHEBI:65198

Synonyms

6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-O-sulfo-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
alpha-L-Fuc-(1->2)-beta-D-Gal6S-(1->4)-D-GlcNAc
Fucalpha1-2[6OSO3]Galbeta1-4GlcNAc
L-fucopyranosyl-(1->2)-6-O-sulfo-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
L-fucosyl-(1->2)-6-O-sulfo-beta-D-galactosyl-(1->4)-2-acetamido-2-deoxy-D-glucose
L-fucosyl-(1->2)-6-O-sulfo-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosamine

Definition

A linear amino trisaccharide that consists of α-L-fucose, 6-sulfated β-D-galactose and N-acetyl-D-glucosamine units connected in sequence by (1→2) and (1→4) links, respectively.

References

glygen:G84693CG
glytoucan:G84693CG
pubmed:19443021

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-D-GlcpNAc

Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-D-GlcpNAc

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-D-GlcpNAc

Phenotype affecting alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-D-GlcpNAc

Human Disease Model